Original Research
Accepted on 14 Aug 2025
Safety and clinical outcomes of orelabrutinib, lenalidomide plus sintilimab for relapsed/refractory diffuse large B-cell lymphoma
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 14 Aug 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 14 Aug 2025
in Healthcare Professions Education
Original Research
Accepted on 14 Aug 2025
in Gastroenterology
Original Research
Accepted on 14 Aug 2025
in Rheumatology
Original Research
Accepted on 14 Aug 2025
in Children and Health
Original Research
Accepted on 14 Aug 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 14 Aug 2025
in Neuro-Ophthalmology
Case Report
Accepted on 14 Aug 2025
in Nuclear Medicine
Original Research
Accepted on 14 Aug 2025
in Oral Health Promotion
Original Research
Accepted on 14 Aug 2025
in Neuromorphic Engineering
Original Research
Accepted on 14 Aug 2025
in Veterinary Humanities and Social Sciences
Brief Research Report
Accepted on 14 Aug 2025
in Pharmacoepidemiology
Case Report
Accepted on 14 Aug 2025
in Hematologic Malignancies
Original Research
Accepted on 14 Aug 2025
in Microbe and Virus Interactions with Plants
Original Research
Accepted on 14 Aug 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 14 Aug 2025
in Cancer Immunity and Immunotherapy